Verified reporting on patents, licensing, invention commercialisation, intellectual-property policy and the disputes that shape who can build what comes next. Updated daily.
The agreement gives Novo exclusive global rights to apply PharmaShell to as many as five peptide-drug programs. Monthly and quarterly injections are targets, not approved products, and most of the headline value remains contingent on development and sales.
Read story
The agreement, effective April 1, 2027, preserves Apple's access to Qualcomm's global patent portfolio even as Apple reduces its reliance on Qualcomm modem chips. Duration and financial terms were not disclosed.
Read story
The programme connects project teams, educators and international evaluators through structured presentation, recognition and post-event visibility.
Read story